Ulrike Köhl (Ulrike Koehl)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Stem Cell Transplantation

Palliative Care

Top Venues

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Renner, Anika Stahringer, Katharina Eva Ruppel, Stephan Fricke, Ulrike Köhl, Dominik Schmiedel
Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells. Gene therapy 31 (7-8) (2024)
Alexander Renner, Anika Stahringer, Katharina Eva Ruppel, Stephan Fricke, Ulrike Köhl, Dominik Schmiedel
Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells. Gene therapy (2024)
Alexander Renner, Anika Stahringer, Katharina Eva Ruppel, Stephan Fricke, Ulrike Köhl, Dominik Schmiedel
Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells. Gene therapy 31 (7-8) (2024)
Alexander Renner, Anika Stahringer, Katharina Eva Ruppel, Stephan Fricke, Ulrike Köhl, Dominik Schmiedel
Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells. Gene therapy 31 (7-8) (2024)
Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy, Stephen Henry Gilbert
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ precision oncology 8 (1) (2024)
Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy, Stephen Henry Gilbert
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ precision oncology 8 (1) (2024)
Bouchra Derraz, Gabriele Breda, Christoph Kaempf, Franziska Baenke, Fabienne Cotte, Kristin Reiche, Ulrike Köhl, Jakob Nikolas Kather, Deborah Eskenazy, Stephen Henry Gilbert
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology. NPJ precision oncology 8 (1) (2024)
Bettina Glatte, Kerstin Wenk, Anja Grahnert, Maik Friedrich, Maximilian Merz, Vladan Vucinic, Luise Fischer, Kristin Reiche, Miriam Alb, Michael Hudecek, Paul Franz, Stephan Fricke, Uwe Platzbecker, Ulrike Köhl, Ulrich Sack, Andreas Boldt, Sunna Hauschildt, Ronald Weiss
Teclistamab impairs detection of BCMA CAR-T cells. Blood advances (2023)